News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

W. L. Gore & Associates, Inc. Launches Early Cannulation Capable GORE® ACUSEAL Vascular Graft



11/20/2013 9:38:44 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FLAGSTAFF, Ariz. & NEW YORK--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced the launch of the GORE ACUSEAL Vascular Graft for vascular access. Designed for early cannulation within 24 hours after implantation, the GORE ACUSEAL Vascular Graft expands treatment options for earlier removal or possible avoidance of a central venous catheter – a major source of infection for hemodialysis patients. The Food and Drug Administration (FDA) cleared the GORE ACUSEAL Vascular Graft in April 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES